Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMC2 pseudogene 2 (PSMC2P2) is a non-protein-coding pseudogene derived from the functional gene encoding Proteasome 26S subunit, ATPase 2 (PSMC2)[4]. Pseudogenes like PSMC2P2 do not produce functional proteins, and there is no evidence that PSMC2P2 has any biological or pathological roles, nor is it a therapeutic target. In contrast, the parent gene PSMC2 encodes an essential ATPase subunit of the 26S proteasome with established roles in protein degradation, cell cycle regulation, and oncogenesis[1][2][3]. However, these functions do not apply to the pseudogene. \nKey notes: \n- The term \"PSMC2 pseudogene 2\" refers specifically to a nonfunctional, likely non-expressed genomic locus and not to an active protein or actionable therapeutic target. \n- Information found for the active gene (PSMC2) should not be attributed to this pseudogene. \n- Pseudogenes are generally ignored in drug targeting and clinical contexts unless shown to exert regulatory functions, which is not the case here.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, ATPase 2 pseudogene 2 (PSMC2P2).